Skip to main content
. Author manuscript; available in PMC: 2015 Mar 27.
Published in final edited form as: Endocr Relat Cancer. 2013 Nov 4;20(6):R341–R356. doi: 10.1530/ERC-13-0364

Table 1.

FlnA-interacting proteins that promote or inhibit metastasis

Inhibits metastasis Promotes metastasis
AR (Wang) B1 integrin (Kim et al. 2007)
IGFBP5 (Abrass & Hansen 2010) PtdIns(3,4,5)P(3) (Takabayashi et al. 2010)
RNA polymerase, POL III (Deng et al. 2012) Sphingosine kinase 1 (Maceyka et al. 2008)
ASB2 (Heuze et al. 2008, Razinia et al. 2011) BRCA2 (Yuan & Shen 2001)
PEBP2β (Yoshida et al. 2005) VEGF (Uramoto et al. 2010)
FoxC1/PBX1 (Berry et al. 2005) c-Met (Zhou)
Klotho (Camilli et al. 2011) R-Ras (Gawecka et al. 2010)
Granzyme B (Browne et al. 2000) RhoA
Cyclin B1 (Cukier et al. 2007)
K-Ras (Nallapalli et al. 2012)
cdc25C (Telles et al. 2011)
BRCA1 (Velkova et al. 2010)
Cyclin D1/cyclin-dependent kinase 4 (Zhong et al. 2010)
Vimentin (MacPherson & Fagerholm 2010)
MLL (De Braekeleer et al. 2009)
Caveolin-1 (Ravid et al. 2008)
TGF-β (Mishra & Marshall 2006)
Arp2/3 (Flanagan et al. 2001)
Pro-PrP (Li et al. 2010)
EGFR (Sy)
P73α (Ravid et al. 2008)